Central Florida Retina (CFR) is successfully reaching the end of our two year Diabetic Macular Edema study. We have also completed year one of our Wet Age Related Macular Degeneration study and are looking forward to merging into an extension study for the same AMD disease process. CFR is also excited about the new clinical trial treatment options on the horizon and we hope to be a part of several biotechnologies studies for AMD and Vein Occlusion; as well as a potential dry AMD study by the fall. With over 20 years in clinical research experience our physicians and technical staff at CFR are proud to offer treatment options to patients as well as collecting credible data for sponsors to ensure the next generation of retina disease therapies. For more information contact our clinical research department at 1.800.255.7188.

Central Florida Retina has over 20 years experience in research including current treatments for Macular Degeneration with Lucentis and Visudyne.

Actively enrolling subjects with:

• Dry Macular Degeneration
• Wet Macular Degeneration (recently diagnosed with no previous treatment)

Ongoing studies for subjects with:

• Diabetic Macular Edema
• Retinal Vein Oclusion
• Macular Degeneration

You may contact our office if you are interested in participating in one of our trials. Please ask to speak with our Research Coordinator.